We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · December 31, 2021

Interferon Beta-1a Treatment Promotes COVID-19 Vaccine Response in MS Patients

Multiple Sclerosis and Related Disorders


Additional Info

Disclosure statements are available on the authors' profiles:

Multiple Sclerosis and Related Disorders
Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects
Mult Scler Relat Disord 2022 Feb 01;58(xx)103455, GT Maniscalco, V Manzo, AL Ferrara, A Perrella, M Di Battista, S Salvatore, D Graziano, A Viola, G Amato, O Moreggia, D Di Giulio Cesare, S Barbato, G Servillo, K Longo, M Di Giovanni, B Scarpati, SM Muggianu, G Longo, G Russo, V Andreone, V De Rosa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading